Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US

Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US
Health experts are concerned by the simultaneous spread of three respiratory illnesses in the United States. (Photo: Getty)
Dan Brunskill
Fisher & Paykel Healthcare has reported half-year earnings ahead of analyst expectations and their own market guidance, with operating revenue at $690.6 million.The company had told the market to expect revenue to be $670m in its August trading update, warning that many customers were already stocked up on hospital products.Even though the higher-than-expected revenue was 23% lower than in the first half of the prior year, it was a 21% increase on the pre-pandemic period first half of 2020.Fisher & Paykel Healthcare's (FPH) chief ex...

More Markets

Why does NZ suck at building brands
Markets

Eden Bradfield: Why does NZ suck at building brands

Let the French have Fonterra brands, Eden Bradfield writes.

NZ sharemarket ends week up 2.2%
Markets Market Close

NZ sharemarket ends week up 2.2%

The S&P/NZX 50 Index closed at 13,223.53, up 90.32 points or 0.69%.

Graham Skellern 05 Sep 2025
Fletcher Building slashes maximum CEO pay
Markets

Fletcher Building slashes maximum CEO pay

 Total maximum remuneration is now $2m lower at $5.8m.

Rebecca Howard 05 Sep 2025
Westpac NZ eyes monetary policy reform for change-laden RBNZ
Economy

Westpac NZ eyes monetary policy reform for change-laden RBNZ

Westpac NZ puts monetary policy voting in the spotlight.

Staff reporters 05 Sep 2025